Domestic & International
Dragon Pharma, Europe
Superdrol
Oral · 10 mg · 100 tabs
$56.00
Compound ID
Methyldrostanolone
Dosage
10–20 mg/day
Concentration
10 mg/tablet
Form
100 Tablets × 10 mg
Half-life
8–12 hours
Properties
Shipping
Not available in this combination
Product overview
Dragon Pharma Methyldrostanolone 10mg — Ultra-Potent Dry Mass Architect for Rapid Lean Hypertrophy & Competition-Grade Density
Dragon Pharma Methyldrostanolone 10mg, universally recognized throughout the performance community as Superdrol, represents one of the most aggressively potent oral anabolic-androgenic steroids ever synthesized for short-cycle physique transformation. Engineered as a C17-alpha alkylated derivative of drostanolone, this non-aromatizing compound delivers rapid, substantial lean tissue accretion and explosive strength escalation without the subcutaneous fluid accumulation that obscures definition.
Users consistently report 10–15 pounds of dry, hard muscle within a mere 3–4 week window, accompanied by a level of muscular density and vascularity typically reserved for pre-contest pharmaceutical protocols. Dragon Pharma's precisely manufactured 10mg tablets provide the dosing granularity necessary for controlled administration of this formidable agent—though its extraordinary anabolic power is matched by a severe side-effect profile demanding meticulous cycle planning, aggressive organ protection, and unwavering respect for its hepatotoxic and suppressive potential.
What is Dragon Pharma Methyldrostanolone?
Methyldrostanolone is a synthetic oral anabolic-androgenic steroid structurally derived from Masteron (drostanolone) through the addition of a 17-alpha-methyl group, enabling oral bioavailability by resisting first-pass hepatic degradation. Unlike its injectable parent compound, Superdrol does not aromatize via the aromatase enzyme and possesses no progestogenic activity, eliminating estrogenic complications entirely while retaining profound anabolic and androgenic potency.
Originally introduced as a dietary supplement during the early 2000s before regulatory reclassification, this compound rapidly earned legendary status for its ability to produce steroid-like mass and strength outcomes in abbreviated timeframes. Dragon Pharma's 10mg oral tablets deliver this high-risk, high-reward agent with pharmaceutical manufacturing precision, ensuring that each dose unit provides exactly the stated pharmacological payload required for predictable short-cycle programming.
Key Benefits / Effects
- Rapid Dry Hypertrophy: Users consistently achieve 10–15 pounds of lean, contractile tissue within 3–4 weeks, characterized by minimal to zero subcutaneous water retention and a distinctly hard, grainy aesthetic.
- Explosive Neuromuscular Strength: Compound lift performance frequently surges within the first 5–7 days, with users adding substantial load to major movements and shattering previous personal records.
- Extreme Muscular Fullness & Pumps: Intramuscular glycogen supercompensation and enhanced blood volume create a dramatically full, pumped appearance that can become intensely pronounced during training sessions.
- Pronounced Vascular Definition: The absence of estrogenic fluid retention combined with increased hematocrit produces striking vein visibility and muscle separation, even in non-training states.
- Non-Estrogenic Recomposition: Complete absence of aromatization eliminates gynecomastia risk, bloating, and estrogen-mediated blood pressure elevation, streamlining cycle management.
- Versatile Cycle Positioning: Functions effectively as both a frontloaded kickstarter for mass-building injectable cycles and as a late-stage finisher to add final dry fullness and hardness before competition.
How Dragon Pharma Methyldrostanolone Works
Superdrol initiates its effects through high-affinity binding to androgen receptors within skeletal myocytes, triggering robust upregulation of muscle-specific protein synthesis, nitrogen retention, and myonuclear domain expansion. The compound's structural relationship to drostanolone confers strong anabolic character while the C17-alpha alkylation ensures sufficient oral bioavailability to produce systemic physiological changes. Because it cannot interact with the aromatase enzyme, all anabolic signaling occurs within a purely androgenic environment—maximizing contractile tissue development without parallel estrogenic pathway activation that would otherwise promote fluid retention and adipogenesis.
Additionally, Methyldrostanolone stimulates erythropoietic activity, increasing red blood cell production and oxygen-carrying capacity, which contributes to both the dramatic training pumps and enhanced muscular endurance reported by users. The same C17-aa modification that enables oral administration, however, imposes severe oxidative stress on hepatic enzyme systems, creating a narrow therapeutic window that strictly limits cycle duration and mandates comprehensive liver protection protocols.
Usage Information
Dragon Pharma Methyldrostanolone is supplied as 10mg oral tablets and is reserved for experienced male athletes with prior anabolic steroid exposure. Due to its extreme hepatotoxicity and suppressive nature, cycle duration must be strictly limited to 3–4 weeks, with an absolute maximum of 6 weeks under exceptional circumstances. The standard effective dose consists of 20mg daily, split into two 10mg administrations to maintain stable plasma concentrations and reduce peak hepatic stress. A minority of advanced users may cautiously explore 30mg daily, though doses beyond this threshold produce exponentially increasing side effects with diminishing anabolic returns.
Superdrol is almost never used as a standalone compound; a testosterone base—typically Testosterone Cypionate or Enanthate at 400mg weekly—is mandatory to maintain physiological androgen levels, preserve libido, and prevent severe low-testosterone symptoms. Because the compound itself does not aromatize, aromatase inhibitors are only necessary to manage estrogen from the concurrent testosterone base. Aggressive liver support with TUDCA and NAC is non-negotiable throughout administration. A robust Post-Cycle Therapy protocol must commence after cycle completion to restore endogenous testosterone production.
Quality & Manufacturing
Dragon Pharma enforces uncompromising pharmaceutical manufacturing standards, with each Methyldrostanolone batch subjected to independent third-party laboratory analysis to verify identity, purity, and potency. The 10mg tablets are produced under controlled conditions to ensure uniform active ingredient distribution and consistent dissolution, supporting predictable pharmacokinetics during the brief but intense cycles characteristic of this compound. In the oral steroid marketplace, where Superdrol products are frequently underdosed, contaminated with prohormones, or inconsistently manufactured, this level of analytical transparency is essential for both efficacy and safety.
A tablet falling short of its 10mg claim would fail to produce the legendary rapid gains users expect, while an unpredictably overdosed alternative could expose athletes to dangerous levels of hepatotoxicity and cardiovascular stress. Dragon Pharma's verified dosing consistency provides the precision required to program short, aggressive cycles with mathematical confidence.
Possible Side Effects / Safety Information
- Severe Hepatotoxicity: The C17-alpha alkylation necessary for oral bioavailability places extreme strain on hepatic enzyme systems. Significant ALT and AST elevations are common even at moderate doses for brief durations. Cycle length must not exceed 4–6 weeks, and aggressive liver support is absolutely mandatory.
- Profound Dyslipidemia: Superdrol is notorious for dramatically depressing HDL cholesterol while elevating LDL cholesterol and triglycerides, creating a severely unfavorable lipid profile that necessitates dietary vigilance and cardiovascular monitoring.
- Debilitating Lethargy and Fatigue: Often termed "Superdrol fatigue," this profound exhaustion is thought to stem from hepatic stress and potential thyroid hormone disruption. It can become debilitating enough to impair daily functioning and training motivation.
- Appetite Suppression: Many users experience significant loss of hunger, complicating the high caloric intake required to maximize anabolic potential and often contributing to the fatigue complex.
- Hypothalamic-Pituitary-Gonadal Axis Suppression: Methyldrostanolone rapidly and completely shuts down endogenous testosterone production. A testosterone base during the cycle and comprehensive PCT afterward are non-negotiable.
- Androgenic Manifestations: Users may experience acne vulgaris, accelerated male pattern baldness in genetically predisposed individuals, and increased terminal hair growth.
- Cardiovascular Hypertension: Increased blood viscosity, hematocrit elevation, and lipid profile deterioration can produce significant blood pressure increases requiring regular monitoring.
- Intramuscular Pump Discomfort: The extreme fullness and blood volume increases can produce pumps so intense they become painful or interfere with training completion.
Why Choose Dragon Pharma Methyldrostanolone?
When manipulating a compound of such extreme potency and narrow therapeutic index, product integrity becomes the decisive variable separating transformative results from dangerous uncertainty. Dragon Pharma's commitment to analytical verification and batch consistency ensures that each 10mg tablet delivers exactly the stated pharmacological payload, eliminating the guesswork of underdosed or counterfeit alternatives.
For experienced bodybuilders who have exhausted milder oral options and demand the most aggressive short-cycle dry mass and strength outcomes available, this verified formulation provides a precisely quantified tool. The brand's manufacturing precision allows athletes to focus entirely on managing the compound's profound effects and risks—knowing that their dosing calculations are based on accurate, predictable potency rather than marketplace speculation.
The Superdrol is incredible. Pumps like you would not believe. High quality product with high purity. 20mg/day for 3 weeks and I gained highly visible quality muscle tissue that stays after my cut. 10/10
On week 3 and it’s kickin. Best around 100%
Product FAQ
Questions, answered
Methyldrostanolone is among the fastest-acting oral anabolic agents available. Most users report noticeable increases in training pumps, vascularity, and scale weight within the first 3–5 days. Visible lean mass changes and strength breakthroughs typically consolidate by the end of week one, with maximal dry tissue accretion and density appearing during weeks 2–4. The rapid onset makes it exceptionally effective as a cycle kickstarter or brief peaking agent.
The C17-alpha alkylation required for oral bioavailability imposes severe cumulative hepatic stress that escalates dramatically beyond the 3–4 week mark. While compounds like Turinabol or Anavar may be used for 6–8 weeks, Superdrol's hepatotoxicity profile is substantially more aggressive. Additionally, the profound suppression and debilitating fatigue that often accompany extended use make longer protocols physically unsustainable for most users. The compound is explicitly designed for brief, explosive deployment rather than sustained administration.
Methandienone produces rapid, dramatic weight gain accompanied by significant water retention, explosive strength increases, and substantial estrogenic side-effect management requirements. Superdrol generates comparably rapid lean tissue accretion but with a characteristically dry, hard aesthetic devoid of subcutaneous fluid. The gains from Superdrol are higher quality and more permanent, though the side-effect burden—particularly hepatotoxicity, lipid destruction, and lethargy—far exceeds that of Methandienone. Dianabol is more forgiving for beginners; Superdrol is reserved for advanced users seeking maximum dryness.
The profound lethargy associated with Methyldrostanolone is multifactorial, likely involving hepatic metabolic burden, potential suppression of thyroid hormone conversion, and the body's general stress response to extreme anabolic signaling. Management strategies include aggressive liver support with TUDCA at 750–1000mg daily, maintenance of adequate complex carbohydrate intake to sustain energy, splitting doses to avoid plasma concentration spikes, and ensuring optimal hydration. Some users find that keeping dietary fats moderate and incorporating light cardiovascular activity helps mitigate the sluggishness. Ultimately, the most effective management is strict adherence to short cycle lengths.
Yes. Methyldrostanolone rapidly and completely suppresses endogenous testosterone production, producing severe low-androgen symptoms including lethargy, libido collapse, erectile dysfunction, joint pain, and depression. A testosterone base—typically 400mg weekly of Testosterone Cypionate or Enanthate—maintains physiological androgen levels, preserving mental clarity, sexual function, and quality of life while Superdrol drives rapid anabolic progress. Because testosterone aromatizes, an aromatase inhibitor may be needed to manage estrogen from the base.
Given its extreme hepatotoxic potential, Superdrol requires the most aggressive liver support protocols available. Standard recommendations include TUDCA at 750–1000mg daily and N-acetylcysteine (NAC) at 1200–2400mg daily. Additional support may include milk thistle, Liv-52, or glutathione precursors. Complete alcohol abstinence is mandatory, as is avoidance of acetaminophen, NSAIDs, and all other hepatotoxic substances. Pre-cycle liver enzyme baselines must be established, with mid-cycle monitoring at day 10–14 to assess hepatic status. Cycle termination should be considered if ALT or AST exceed three times the upper reference limit.
No. Methyldrostanolone does not aromatize to estrogen and possesses no progestogenic activity, completely eliminating the risk of gynecomastia, subcutaneous water retention, and estrogenic blood pressure elevation. This is one of Superdrol's primary attractions—the physique changes are purely dry, dense, and vascular. However, users employing a testosterone base must still manage estrogen derived from the exogenous testosterone via aromatase inhibitors if necessary.
PCT must be comprehensive due to the depth of suppression. A standard protocol includes Clomiphene Citrate at 50/50/25/25mg and Tamoxifen Citrate at 40/20/20/20mg over four weeks. For users who employed a testosterone base, PCT timing should account for ester clearance—longer esters like Cypionate or Enanthate require approximately two weeks between final injection and SERM initiation. HCG at 500–1000IU every other day for the two weeks preceding PCT can prime testicular responsiveness. Blood work confirming recovered LH, FSH, and total testosterone should precede any subsequent cycle.
Stacking Superdrol with other C17-alpha alkylated orals is strongly discouraged and considered dangerous. The combined hepatotoxic burden from multiple liver-stressing compounds can produce severe, potentially irreversible hepatic damage. If combination therapy is desired, it should be limited to non-alkylated injectable agents such as Testosterone, Drostanolone, or Methenolone. Some advanced users stack with injectable Masteron to amplify dryness and hardness, but oral stacking should be avoided entirely.
Because Superdrol gains are dry and high-quality, they are more sustainable than fluid-mediated bulk—but only with proper post-cycle strategy. Maintaining a caloric surplus or at minimum maintenance calories during PCT signals the body to retain new contractile tissue. Abruptly cutting calories post-cycle accelerates catabolism. Continuing resistance training with high intensity, completing a full PCT protocol, and maintaining protein intake at 1g per pound of body weight all support tissue retention. Some users incorporate non-suppressive compounds like MK-677 or creatine during recovery to support anabolism while hormones normalize.
Baseline panels must include total and free testosterone, estradiol, complete blood count, comprehensive metabolic panel with liver enzymes (ALT, AST, ALP, GGT, bilirubin), and a full lipid profile. Blood pressure should be monitored every 48–72 hours. Mid-cycle testing at day 10–14 identifies emerging hepatic stress, hematocrit elevation, or dyslipidemia. Post-cycle panels at weeks 2 and 4 after cessation confirm hormonal recovery and metabolic normalization. Given the extreme risk profile, these safeguards are absolutely non-negotiable.
No. Methyldrostanolone is explicitly an advanced compound reserved for experienced users with multiple prior cycles and thorough understanding of anabolic side-effect management. Its severe hepatotoxicity, profound suppression, debilitating fatigue, and aggressive lipid impact create a side-effect profile that beginners are ill-equipped to recognize or manage. Novice users should begin with milder, more forgiving compounds such as Turinabol or conservative testosterone-only protocols before considering Superdrol.
